How to design efficient cluster randomised trials

Cluster randomised trials have diminishing returns in power and precision as cluster size increases. Making the cluster a lot larger while keeping the number of clusters fixed might yield only a very small increase in power and precision, owing to the intracluster correlation. Identifying the point at which observations start making a negligible contribution to the power or precision of the study—which we call the point of diminishing returns—is important for designing efficient trials. Current methods for identifying this point are potentially useful as rules of thumb but don’t generally work well. We introduce several practical aids to help researchers design cluster randomised trials in which all observations make a material contribution to the study. Power curves enable identification of the point at which observations begin to make a negligible contribution to a study for a given target difference. Under this paradigm, the number needed per arm under individual randomisation gives an upper bound on the cluster size, which should not be exceeded. Corresponding precision curves can be useful for accommodating flexibility in the choice of target difference and show the point at which confidence intervals around the estimated effect size no longer decrease. To design efficient trials, the number of clusters and cluster size should be determined concurrently, not independently. Funders and researchers should be aware of diminishing returns in cluster trials. Researchers should routinely plot power or precision curves when performing sample size calculations so that the implications of cluster sizes can be transparent. Even when data appear to be “free,” in the sense that few resources are needed to obtain the data, excessive cluster sizes can have important ramifications

[1]  J. Bland,et al.  The tyranny of power: is there a better way to calculate sample size? , 2009, BMJ : British Medical Journal.

[2]  G. Lancaster,et al.  How big should the pilot study for my cluster randomised trial be? , 2016, Statistical methods in medical research.

[3]  P. Ravaud,et al.  A priori postulated and real power in cluster randomized trials: mind the gap , 2005, BMC medical research methodology.

[4]  A Donner,et al.  Statistical considerations in the design and analysis of community intervention trials. , 1996, Journal of clinical epidemiology.

[5]  Michael J. Campbell,et al.  How to Design, Analyse and Report Cluster Randomised Trials in Medicine and Health Related Research , 2014 .

[6]  Allan Donner,et al.  Some aspects of the design and analysis of cluster randomization trials , 2002 .

[7]  L. Bourke,et al.  Cluster randomised trials with repeated cross sections: alternatives to parallel group designs , 2015, BMJ : British Medical Journal.

[8]  R Peto,et al.  Large-scale randomized evidence: large, simple trials and overviews of trials. , 1993, Annals of the New York Academy of Sciences.

[9]  Derek C Angus,et al.  Fusing Randomized Trials With Big Data: The Key to Self-learning Health Care Systems? , 2015, JAMA.

[10]  Sally Kerry,et al.  A Practical Guide to Cluster Randomised Trials in Health Services Research , 2012 .

[11]  Steven Teerenstra,et al.  Substantial risks associated with few clusters in cluster randomized and stepped wedge designs , 2016, Clinical trials.

[12]  A Donner,et al.  Developments in cluster randomized trials and Statistics in Medicine , 2007, Statistics in medicine.

[13]  Chris Woolston Psychology journal bans P values , 2015, Nature.

[14]  B. Carter Cluster size variability and imbalance in cluster randomized controlled trials , 2010, Statistics in medicine.

[15]  M K Campbell,et al.  Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. , 2001, Statistics in medicine.

[16]  Karla Hemming,et al.  Erratum to: Sample size calculations for cluster randomised controlled trials with a fixed number of clusters , 2017, BMC Medical Research Methodology.